moxifloxacin has been researched along with Osteomyelitis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Arhin, FF; Caron, L; Delorme, D; Dietrich, E; Fadhil, I; Ferreira, SS; Houghton, TJ; Kang, T; Laquerre, K; Lehoux, D; Liu, J; Moeck, G; Ostiguy, V; Parr, TR; Poirier, H; Rafai Far, A; Sarmiento, I; Tanaka, KS; Viens, F | 1 |
| Arhin, FF; Delorme, D; Dietrich, E; Fadhil, I; Far, AR; Ferreira, SS; Houghton, TJ; Kang, T; Lafontaine, Y; Laquerre, K; Lehoux, D; Liu, J; Moeck, G; Ostiguy, V; Parr, TR; Poirier, H; Sarmiento, I; Tanaka, KS; Viens, F | 1 |
| Aguilera-Correa, JJ; Carias-Cálix, RA; Esteban, J; Gisbert-Garzarán, M; Jiménez-Jiménez, C; Mediero, A; Vallet-Regí, M | 1 |
| Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N | 1 |
| Abdeltawab, NF; Awad, GAS; Ishak, RAH; Nasr, M; Radwan, NH | 1 |
| Awad, GAS; Ishak, RAH; Nasr, M; Radwan, NH | 1 |
| Choreftaki, T; Galanopoulos, I; Giamarellos-Bourboulis, EJ; Giannitsioti, E; Kanellakopoulou, K; Papalois, A; Poultsides, LA; Soranoglou, V | 1 |
| Chouiter, A; Lebowitz, D; Malinverni, R; Wolter, L; Zenklusen, C | 1 |
| Galanopoulos, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Maris, I; Papalois, A; Soranoglou, V; Tsaganos, T; Tziortzioti, V | 1 |
| Dugar, M; Rankin, WA; Rowe, E; Smith, MD | 1 |
| Cakici, H; Guven, M; Kocoglu, E; Ozturan, KE; Yucel, I | 1 |
| Baldelli, F; Canovari, B; Cerulli, G; Egidi, AM; Francisci, D; Ghebregzabher, M; Malincarne, L; Moretti, MV; Tavolieri, G | 1 |
| Beckmann, J; Kalteis, T; Lehn, N; Lerch, K; Linde, HJ; Schaumburger, J; Schröder, HJ | 1 |
| Beckmann, J; Grifka, J; Handel, M; Kalteis, T; Lehn, N; Lerch, K; Schröder, HJ | 1 |
| Athanassiou, K; Giamarellou, H; Kanellakopoulou, K; Koutoukas, P; Raftogiannis, M; Skiadas, I; Tsaganos, T | 1 |
| Alexiadou, E; Charokopos, N; Koumentaki, E; Lazaraki, G; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Theodoridis, G; Tsona, A | 1 |
| Alexiadou, E; Grovaris, L; Lazaraki, G; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Theodoridou, A; Topsis, D | 1 |
| Ang, JY; Asmar, BI | 1 |
2 trial(s) available for moxifloxacin and Osteomyelitis
| Article | Year |
|---|---|
Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.
Topics: Administration, Oral; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Aza Compounds; Biological Availability; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Leg Bones; Male; Moxifloxacin; Osteomyelitis; Quinolines; Tissue Distribution | 2006 |
Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cardiopulmonary Bypass; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Manubrium; Middle Aged; Moxifloxacin; Osteomyelitis; Quinolines; Sternum | 2006 |
16 other study(ies) available for moxifloxacin and Osteomyelitis
| Article | Year |
|---|---|
Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis.
Topics: Animals; Disease Models, Animal; Esters; Female; Fluoroquinolones; Humans; Molecular Structure; Organophosphonates; Osteomyelitis; Prodrugs; Rats | 2008 |
Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.
Topics: Amines; Animals; Cell Line; Diphosphonates; Female; Fluoroquinolones; Molecular Structure; Osteomyelitis; Prodrugs; Rats; Structure-Activity Relationship | 2008 |
Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Colistin; Escherichia coli; Moxifloxacin; Nanoparticles; Osteomyelitis; Rabbits; Silicon Dioxide | 2022 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Chitosan-calcium phosphate composite scaffolds for control of post-operative osteomyelitis: Fabrication, characterization, and in vitro-in vivo evaluation.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Chitosan; Drug Carriers; Humans; Moxifloxacin; Osteoblasts; Osteomyelitis; Rabbits; Tissue Scaffolds | 2020 |
Moxifloxacin-loaded in situ synthesized Bioceramic/Poly(L-lactide-co-ε-caprolactone) composite scaffolds for treatment of osteomyelitis and orthopedic regeneration.
Topics: Animals; Caproates; Dioxanes; Lactones; Moxifloxacin; Osteomyelitis; Polyesters; Tissue Engineering; Tissue Scaffolds | 2021 |
Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cancellous Bone; Cortical Bone; Debridement; Disease Models, Animal; Fluoroquinolones; Histocytochemistry; Humans; Injections, Intramuscular; Male; Methicillin-Resistant Staphylococcus aureus; Moxifloxacin; Osteomyelitis; Rabbits; Staphylococcal Infections; Treatment Outcome | 2017 |
TB determined: tuberculous osteomyelitis.
Topics: Antitubercular Agents; Aza Compounds; Bone Neoplasms; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fluorodeoxyglucose F18; Fluoroquinolones; Humans; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Moxifloxacin; Osteomyelitis; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Rifampin; Spine; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2014 |
Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bone and Bones; Calcium Sulfate; Colony Count, Microbial; Delayed-Action Preparations; Fluoroquinolones; Male; Methicillin-Resistant Staphylococcus aureus; Moxifloxacin; Osteomyelitis; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome | 2009 |
"My foot hurts": a flare of rheumatoid arthritis?
Topics: Arthritis, Rheumatoid; Aza Compounds; Azithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Legionella longbeachae; Legionellosis; Male; Middle Aged; Moxifloxacin; Neutropenia; Osteomyelitis; Quinolines; Steroids | 2009 |
Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Disease Models, Animal; Fluoroquinolones; Injections, Intraperitoneal; Male; Moxifloxacin; Osteomyelitis; Prosthesis-Related Infections; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Outcome | 2010 |
Treatment of implant-associated infections with moxifloxacin: an animal study.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Implants, Experimental; Male; Moxifloxacin; Osteomyelitis; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Vancomycin | 2006 |
Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Femur; Fluoroquinolones; Male; Moxifloxacin; Osteomyelitis; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study.
Topics: Absorbable Implants; Anti-Bacterial Agents; Aza Compounds; Bone Cements; Calcium Phosphates; Chromatography, High Pressure Liquid; Drug Carriers; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Quinolines | 2006 |
Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Aza Compounds; Bone and Bones; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Humans; Injections, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Osteomyelitis; Quinolines | 2007 |
Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Debridement; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Mandibular Diseases; Moxifloxacin; Osteomyelitis; Quinolines; Streptococcal Infections; Viridans Streptococci | 2008 |